Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
D000818:Animals; D000956:Antigens, Viral; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004854:Herpesvirus 4, Human / Q000254:growth & development* / Q000276:immunology; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology*; D007942:Leukemia, Experimental; D008938:Mitosis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects*
D000956:Antigens, Viral; D004273:DNA, Neoplasm; D014764:Viral Proteins; D014316:Tritium; D007065:Idoxuridine; D013936:Thymidine